Head, Developmental Therapeutics Clinic
National Institutes of Health
Dr. Chen is the head of the Developmental Therapeutics Clinic (DTC) since 2014. Within the DTC, NCI facilitates the discovery and development of new anticancer drugs and drug targets, as well as piloting novel clinical trial designs that can be applied to the development of molecularly targeted agents on a national and international basis. The clinic has over 20 open studies evaluating new agents and MOA as well as rare tumor studies, including sarcoma. She is the director the Advance Developmental Therapeutic Training Program which trains medical oncologists in early phase drug development. Fellows in the program have won major awards including one of the 2020 ASCO Young Investigator awards for atezolizumab in ASPS. Prior to this, she was a Senior Investigator at the Cancer Therapy Evaluation Program, DCTD, NCI handling a portfolio in DNA repair and antiangiogenic agents. Dr. Chen have authored over 100 manuscripts and presented by invitation to major oncology meetings internationally on early phase clinical trials, precision medicine, DNA repair and CTCAE.
